DBV Technologies SA - Company Profile (NASDAQ:DBVT)

About DBV Technologies SA -

DBV Technologies SA - logoDBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: DBVT
  • CUSIP:
Key Metrics:
  • Previous Close: $36.33
  • 50 Day Moving Average: $35.33
  • 200 Day Moving Average: $33.32
  • 52-Week Range: $22.55 - $39.84
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.96
  • P/E Growth: -0.25
  • Market Cap: $1.67B
  • Outstanding Shares: 46,000,000
  • Beta: 1.52
Additional Links:
Companies Related to DBV Technologies SA -:

Analyst Ratings

Consensus Ratings for DBV Technologies SA - (NASDAQ:DBVT) (?)
Ratings Breakdown: 7 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $49.57 (36.45% upside)

Analysts' Ratings History for DBV Technologies SA - (NASDAQ:DBVT)
Show:
DateFirmActionRatingPrice TargetDetails
9/26/2016JMP SecuritiesInitiated CoverageOutperform$47.00View Rating Details
8/23/2016Leerink SwannReiterated RatingBuy$54.00View Rating Details
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details
3/16/2016Citigroup Inc.Lower Price TargetBuy$48.00 -> $43.00View Rating Details
3/7/2016HC WainwrightReiterated RatingBuyView Rating Details
12/3/2015Barclays PLCInitiated CoveragePositive -> Overweight$58.00View Rating Details
10/23/2015Bank of America Corp.Initiated CoverageBuy$48.00View Rating Details
9/15/2015Morgan StanleyInitiated CoverageOverweight$59.00View Rating Details
(Data available from 9/30/2014 forward)

Earnings

Earnings History for DBV Technologies SA - (NASDAQ:DBVT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/26/2015($0.44)($0.79)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for DBV Technologies SA - (NASDAQ:DBVT)
Current Year EPS Consensus Estimate: $-4.61 EPS
Next Year EPS Consensus Estimate: $-5.22 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.70)($0.70)($0.70)
Q4 20161($0.76)($0.76)($0.76)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for DBV Technologies SA - (NASDAQ:DBVT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for DBV Technologies SA - (NASDAQ:DBVT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for DBV Technologies SA - (NASDAQ:DBVT)
DateHeadline
finance.yahoo.com logoCoverage initiated on DBV Technologies by JMP Securities (NASDAQ:DBVT)
finance.yahoo.com - September 26 at 4:46 PM
publicnow.com logoDBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy (NASDAQ:DBVT)
www.publicnow.com - September 21 at 8:52 AM
publicnow.com logoMonthly information regarding the total number of voting rights and total number of shares of the Company (NASDAQ:DBVT)
www.publicnow.com - September 12 at 9:29 AM
publicnow.com logoDBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination (NASDAQ:DBVT)
www.publicnow.com - September 6 at 9:26 AM
publicnow.com logoDBV Technologies Announces Expansion of Clinical Program of Viaskin Peanut for the Treatment of Peanut Allergy (NASDAQ:DBVT)
www.publicnow.com - August 2 at 9:21 AM
publicnow.com logoFirst Half of 2016 Condensed Consolidated Financial Statements (NASDAQ:DBVT)
www.publicnow.com - July 28 at 5:08 AM
publicnow.com logoDBV Technologies Reports Interim Financial Results for the First Half of 2016 (NASDAQ:DBVT)
www.publicnow.com - July 28 at 1:38 AM
capitalcube.com logoDBV Technologies SA :DBVT-US: Earnings Analysis: For the six months ended December 31, 2015 : July 26, 2016 (NASDAQ:DBVT)
www.capitalcube.com - July 26 at 10:43 AM
investornewswire.com logoStrong Sell Calls For DBV Technologies S.A. (NASDAQ:DBVT) At 0 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - July 16 at 5:15 AM
News IconDbv Tech SA Ads (NASDAQ:DBVT) Shorted Shares Increased By 5.19% - Consumer Eagle (NASDAQ:DBVT)
www.consumereagle.com - July 14 at 7:02 AM
News IconAre Analysts Bearish DBV Technologies SA - ADR (NASDAQ:DBVT) After Last Week? - Consumer Eagle (NASDAQ:DBVT)
www.consumereagle.com - July 12 at 9:56 PM
publicnow.com logoHalf year update on the DBV Technologies liquidity agreement (NASDAQ:DBVT)
www.publicnow.com - July 12 at 4:53 AM
investornewswire.com logoIs $64 Within Reach For DBV Technologies S.A. (NASDAQ:DBVT)? - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - July 8 at 4:34 PM
ftsenews.co.uk logoDBV Technologies S.A. (NASDAQ:DBVT) Updated Price Targets - FTSE News (NASDAQ:DBVT)
www.ftsenews.co.uk - July 5 at 9:16 AM
finance.yahoo.com logoDBV Technologies Proudly Welcomes Dr. Lucia Septien as Chief Medical Officer (NASDAQ:DBVT)
finance.yahoo.com - July 5 at 1:34 AM
fiscalstandard.com logoThis Weeks Broker Price Targets For DBV Technologies S.A. (NASDAQ:DBVT) - Fiscal Standard (NASDAQ:DBVT)
www.fiscalstandard.com - July 4 at 4:19 PM
investornewswire.com logoDBV Technologies S.A. (NASDAQ:DBVT) Expected to Reach Highs Of $64 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - July 1 at 9:40 PM
News IconDbv Tech SA Ads (NASDAQ:DBVT) Sellers Increased By 5.19% Their Shorts - Engelwood Daily (NASDAQ:DBVT)
www.engelwooddaily.com - June 30 at 9:52 AM
News IconWhat's Next for DBV Technologies SA - ADR After Today's Huge Increase? - Engelwood Daily (NASDAQ:DBVT)
www.engelwooddaily.com - June 29 at 9:35 PM
publicnow.com logoDBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children (NASDAQ:DBVT)
www.publicnow.com - June 27 at 4:41 PM
publicnow.com logoDBV Technologies Expands its Board of Directors with the Appointments of Claire Giraut and Maïlys Ferrere (NASDAQ:DBVT)
www.publicnow.com - June 21 at 4:39 PM
publicnow.com logoDBV Announced Results of its 2016 Annual Meeting of Shareholders (NASDAQ:DBVT)
www.publicnow.com - June 21 at 4:39 PM
finance.yahoo.com logoDBV Technologies Announced Results of its 2016 Annual Meeting of Shareholders (NASDAQ:DBVT)
finance.yahoo.com - June 21 at 4:36 PM
finance.yahoo.com logoDBV Technologies Expands its Board of Directors with the Appointments of Claire Giraut and Mailys Ferrere (NASDAQ:DBVT)
finance.yahoo.com - June 21 at 4:32 PM
finance.yahoo.com logoAdobe Systems (ADBE): A Surprise in Q2 Earnings Release? (NASDAQ:DBVT)
finance.yahoo.com - June 17 at 9:11 AM
publicnow.com logoDBV Technologies to Present at the JMP Securities Life Sciences Conference (NASDAQ:DBVT)
www.publicnow.com - June 16 at 4:49 PM
publicnow.com logoLate-Breaking Presentation at EAACI Highlights Viaskin® Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression (NASDAQ:DBVT)
www.publicnow.com - June 15 at 4:39 PM
finance.yahoo.com logoDBV Technologies: Late-Breaking Presentation at EAACI Highlights Viaskin(r) Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression (NASDAQ:DBVT)
finance.yahoo.com - June 15 at 4:34 PM
publicnow.com logoDBV Technologies Announces Appointment of Leading Japanese Allergist, Dr. Motohiro Ebisawa, to its Scientific Advisory Board (NASDAQ:DBVT)
www.publicnow.com - June 7 at 4:38 PM
forbes.com logoDBV Technologies Forms 'Magic' Partnership With Nestle (NASDAQ:DBVT)
www.forbes.com - June 7 at 4:11 PM
finance.yahoo.com logoDBV Technologies Data at EAACI 2016 Highlight Its Expansive Product Development in Food Allergies (NASDAQ:DBVT)
finance.yahoo.com - June 1 at 1:38 AM
wsj.com logoNestle Partnership Gives DBV Investors a Treat (NASDAQ:DBVT)
blogs.wsj.com - May 31 at 1:51 PM
publicnow.com logoDBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy (NASDAQ:DBVT)
www.publicnow.com - May 31 at 9:02 AM
publicnow.com logoJune 21, 2016 General Assembly (NASDAQ:DBVT)
www.publicnow.com - May 31 at 9:02 AM
finance.yahoo.com logoDBV Technologies and Nestle Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy (NASDAQ:DBVT)
finance.yahoo.com - May 31 at 1:06 AM
News IconDbv Tech SA Ads (NASDAQ:DBVT) Shorted Shares Decreased By 11.89% - HNN (NASDAQ:DBVT)
hintsnewsnetwork.com - May 30 at 7:26 PM
investornewswire.com logoStrong Sell Calls Count For DBV Technologies S.A. (NASDAQ:DBVT) At 0 - Investor Newswire (NASDAQ:DBVT)
www.investornewswire.com - May 30 at 7:26 PM
finance.yahoo.com logoDBV Technologies: Mixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly (NASDAQ:DBVT)
finance.yahoo.com - May 30 at 4:46 PM
publicnow.com logoMixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly (NASDAQ:DBVT)
www.publicnow.com - May 30 at 4:40 PM
publicnow.com logoDBV Technologies to Attend Upcoming Investor Conferences (NASDAQ:DBVT)
www.publicnow.com - May 20 at 3:33 AM
publicnow.com logoDBV Technologies Reports March 31, 2016 Cash Position (NASDAQ:DBVT)
www.publicnow.com - April 29 at 1:54 AM
publicnow.com logo20-F Form (NASDAQ:DBVT)
www.publicnow.com - April 28 at 5:41 PM
publicnow.com logoDBV Technologies Announces Filing of 2015 “Document de Référence” and 2015 Annual Report on Form 20-F (NASDAQ:DBVT)
www.publicnow.com - April 28 at 5:41 PM
finance.yahoo.com logoDBV Technologies Announces Filing of 2015 "Document de Reference" and 2015 Annual Report on Form 20-F (NASDAQ:DBVT)
finance.yahoo.com - April 28 at 5:34 PM
publicnow.com logoDBV Technologies Announces Publication of Experimental Data on Targeted Regulatory T Cell Induction during Epicutaneous Immunotherapy (NASDAQ:DBVT)
www.publicnow.com - April 11 at 4:41 PM
clintongazette.com logoDbv Tech SA Ads (NASDAQ:DBVT) Shorted Shares Increased By 10.3% - Clinton Financial (NASDAQ:DBVT)
www.clintongazette.com - February 26 at 1:35 PM
News IconCreating Profits For Investors: DBV Technologies S.A.( NASDAQ:DBVT ) - Franklin Independent (NASDAQ:DBVT)
www.franklinindependent.com - February 26 at 1:35 PM
News IconWere Analysts Bearish DBV Technologies SA - ADR (NASDAQ:DBVT) This Week? - Franklin Independent (NASDAQ:DBVT)
www.franklinindependent.com - February 26 at 1:35 PM
finance.yahoo.com logo5:08 pm DBV Technologies announces the publication of results from a Phase Ib trial showing that Viaskin Peanut was observed to have a favorable safety and tolerability profile (NASDAQ:DBVT)
finance.yahoo.com - February 25 at 5:08 PM
finance.yahoo.com logoDBV Technologies Announces Publication of Phase Ib Trial Results in the Journal of Allergy and Clinical Immunology (JACI) Supporting Safety and Tolerability of Viaskin(R) Peanut (NASDAQ:DBVT)
finance.yahoo.com - February 25 at 4:56 PM

Social

DBV Technologies SA - (NASDAQ:DBVT) Chart for Friday, September, 30, 2016


Last Updated on 9/30/2016 by MarketBeat.com Staff